Found: 7
Select item for more details and to access through your institution.
Helminths' therapeutic potential to treat intestinal barrier dysfunction.
- Published in:
- Allergy, 2023, v. 78, n. 11, p. 2892, doi. 10.1111/all.15812
- By:
- Publication type:
- Article
Editorial: measuring disease severity in inflammatory bowel disease—the whole is greater than the sum of its parts. Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 664, doi. 10.1111/apt.17058
- By:
- Publication type:
- Article
The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease—results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 2, p. 201, doi. 10.1111/apt.16616
- By:
- Publication type:
- Article
Editorial: brain‐gut research needs objective measures of disease activity and mental disorders—authors' reply.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 12, p. 1862, doi. 10.1093/ecco-jcc/jjac098
- By:
- Publication type:
- Article
Modulation of intestinal epithelial permeability by chronic small intestinal helminth infections.
- Published in:
- Immunology & Cell Biology, 2024, v. 102, n. 5, p. 396, doi. 10.1111/imcb.12749
- By:
- Publication type:
- Article